These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 15365685)

  • 21. Neuroendocrine effects of citalopram infusion in anorexia nervosa.
    Mondelli V; Gianotti L; Picu A; Abbate Daga G; Giordano R; Berardelli R; Pariante CM; Fassino S; Ghigo E; Arvat E
    Psychoneuroendocrinology; 2006 Nov; 31(10):1139-48. PubMed ID: 17045409
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Usefulness of serotoninergic challenge with oral citalopram.
    Mattos P; Franco VA; Noel F; Segenreich D; Gonçalves JC
    Braz J Psychiatry; 2006 Sep; 28(3):203-5. PubMed ID: 17063220
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vivo imaging of serotonin transporter occupancy by means of SPECT and [123I]ADAM in healthy subjects administered different doses of escitalopram or citalopram.
    Klein N; Sacher J; Geiss-Granadia T; Attarbaschi T; Mossaheb N; Lanzenberger R; Pötzi C; Holik A; Spindelegger C; Asenbaum S; Dudczak R; Tauscher J; Kasper S
    Psychopharmacology (Berl); 2006 Oct; 188(3):263-72. PubMed ID: 16955282
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of chronic administration of the selective serotonin (5-HT) uptake inhibitor citalopram on extracellular 5-HT and apparent autoreceptor sensitivity in rat forebrain in vivo.
    Auerbach SB; Hjorth S
    Naunyn Schmiedebergs Arch Pharmacol; 1995 Dec; 352(6):597-606. PubMed ID: 9053730
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Decreased platelet 5-hydroxytryptamin (5-HT) levels: a response to antidepressants.
    Li X; Fan Y; Xiao S; Peng S; Dong X; Zheng X; Liu CC; Li H; Xiao Z
    J Affect Disord; 2015 Nov; 187():84-90. PubMed ID: 26321259
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mechanistic model of acute autoinhibitory feedback action after administration of SSRIs in rats: application to escitalopram-induced effects on brain serotonin levels.
    Bundgaard C; Larsen F; Jørgensen M; Gabrielsson J
    Eur J Pharm Sci; 2006 Dec; 29(5):394-404. PubMed ID: 17014998
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Selective serotonin reuptake inhibitor (SSRI) modulation of striatal dopamine measured with [11C]-raclopride and positron emission tomography.
    Smith GS; Ma Y; Dhawan V; Chaly T; Eidelberg D
    Synapse; 2009 Jan; 63(1):1-6. PubMed ID: 18925655
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oral application of citalopram (20 mg) and its usefulness for neuroendocrine challenge tests.
    Henning J; Netter P
    Int J Neuropsychopharmacol; 2002 Mar; 5(1):67-71. PubMed ID: 14609009
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Augmentation with a 5-HT(1A), but not a 5-HT(1B) receptor antagonist critically depends on the dose of citalopram.
    Cremers TI; de Boer P; Liao Y; Bosker FJ; den Boer JA; Westerink BH; Wikström HV
    Eur J Pharmacol; 2000 May; 397(1):63-74. PubMed ID: 10844100
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Additive effect of rimonabant and citalopram on extracellular serotonin levels monitored with in vivo microdialysis in rat brain.
    Ortega JE; Gonzalez-Lira V; Horrillo I; Herrera-Marschitz M; Callado LF; Meana JJ
    Eur J Pharmacol; 2013 Jun; 709(1-3):13-9. PubMed ID: 23562616
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of citalopram on brain serotonin release in experimental hepatic encephalopathy: implications for thymoleptic drug safety in liver insufficiency.
    Bergqvist PB; Wikell C; Hjorth S; Apelqvist G; Bengtsson F
    Clin Neuropharmacol; 1997 Dec; 20(6):511-22. PubMed ID: 9403225
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Administration of citalopram before ECT: seizure duration and hormone responses.
    Papakostas YG; Markianos M; Zervas IM; Theodoropoulou M; Vaidakis N; Daras M
    J ECT; 2000 Dec; 16(4):356-60. PubMed ID: 11314873
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Citalopram--a review of pharmacological and clinical effects.
    Bezchlibnyk-Butler K; Aleksic I; Kennedy SH
    J Psychiatry Neurosci; 2000 May; 25(3):241-54. PubMed ID: 10863884
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of citalopram treatment on hypothermic and hormonal responses to the 5-HT1A receptor agonist buspirone in patients with major depression and therapeutic response.
    Navinés R; Martín-Santos R; Gómez-Gil E; Martínez de Osaba MJ; Imaz ML; Gastó C
    Psychoneuroendocrinology; 2007 May; 32(4):411-6. PubMed ID: 17337123
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Modeling the acute pharmacological response to selective serotonin reuptake inhibitors in human brain using simultaneous PET/MR imaging.
    Gryglewski G; Klöbl M; Berroterán-Infante N; Rischka L; Balber T; Vanicek T; Pichler V; Kautzky A; Klebermass EM; Reed MB; Vraka C; Hienert M; James GM; Silberbauer L; Godbersen GM; Unterholzner J; Michenthaler P; Hartenbach M; Winkler-Pjrek E; Wadsak W; Mitterhauser M; Hahn A; Hacker M; Kasper S; Lanzenberger R
    Eur Neuropsychopharmacol; 2019 Jun; 29(6):711-719. PubMed ID: 31076187
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prolactin and cortisol responses to acute intravenous clomipramine challenge in patients with mania, depression and healthy controls: evidence for reduced serotonergic responsivity.
    Lykouras L; Markianos M; Hatzimanolis Y
    Neuropsychobiology; 2011; 63(2):77-81. PubMed ID: 21178381
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The metabolic syndrome is associated with reduced central serotonergic responsivity in healthy community volunteers.
    Muldoon MF; Mackey RH; Korytkowski MT; Flory JD; Pollock BG; Manuck SB
    J Clin Endocrinol Metab; 2006 Feb; 91(2):718-21. PubMed ID: 16303834
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Higher serotonin transporter occupancy after multiple dose administration of escitalopram compared to citalopram: an [123I]ADAM SPECT study.
    Klein N; Sacher J; Geiss-Granadia T; Mossaheb N; Attarbaschi T; Lanzenberger R; Spindelegger C; Holik A; Asenbaum S; Dudczak R; Tauscher J; Kasper S
    Psychopharmacology (Berl); 2007 Apr; 191(2):333-9. PubMed ID: 17235610
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacokinetics and bioavailability comparison of generic and branded citalopram 20 mg tablets: an open-label, randomized-sequence, two-period crossover study in healthy Chinese CYP2C19 extensive metabolizers.
    Jiang T; Rong Z; Xu Y; Chen B; Xie Y; Chen C; Lu Y; Shen Y; Li H; Sun J; Chen H
    Clin Drug Investig; 2013 Jan; 33(1):1-9. PubMed ID: 23179471
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Selective blockade of 5-hydroxytryptamine (5-HT)7 receptors enhances 5-HT transmission, antidepressant-like behavior, and rapid eye movement sleep suppression induced by citalopram in rodents.
    Bonaventure P; Kelly L; Aluisio L; Shelton J; Lord B; Galici R; Miller K; Atack J; Lovenberg TW; Dugovic C
    J Pharmacol Exp Ther; 2007 May; 321(2):690-8. PubMed ID: 17314195
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.